Radiopharm Theranostics Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	29.12	18.58	11.7	26.98	0.03
Cash & Short-Term Investments	29.12	18.58	11.7	26.98	0.03
Cash Growth	56.75%	58.77%	-56.64%	99486.97%	-
Accounts Receivable	-	-	0.1	0.06	-
Other Receivables	10.4	0.99	4.36	0	0.01
Receivables	10.4	0.99	4.47	0.06	0.01
Other Current Assets	0.34	3.29	0.13	0.23	-
Total Current Assets	39.85	22.85	16.3	27.26	0.03
Property, Plant & Equipment	0.05	0.06	0.07	0	-
Other Intangible Assets	46.57	49.09	58.54	56.08	-
Other Long-Term Assets	-	0.04	0.04	0.04	-
Total Assets	86.48	72.04	74.95	83.38	0.03
Accounts Payable	9.34	6.43	2.96	1.19	0.06
Accrued Expenses	0.45	2.57	2.11	1.02	0.03
Short-Term Debt	-	-	-	-	0.06
Current Unearned Revenue	1.72	-	-	-	-
Other Current Liabilities	3.42	8.57	8.16	5.66	-
Total Current Liabilities	14.93	17.58	13.23	7.88	0.16
Other Long-Term Liabilities	28.68	27.11	16.14	12.54	-
Total Liabilities	43.61	44.68	29.37	20.42	0.16
Common Stock	176.56	100.68	97.23	86.76	0
Retained Earnings	-145.73	-111.34	-65.35	-30.91	-0.49
Comprehensive Income & Other	13.97	38.78	12.51	7.11	0.36
Total Common Equity	44.79	28.12	44.38	62.96	-0.12
Minority Interest	-1.92	-0.77	1.19	-	-
Shareholders' Equity	42.87	27.35	45.58	62.96	-0.12
Total Liabilities & Equity	86.48	72.04	74.95	83.38	0.03
Total Debt	-	-	-	-	0.06
Net Cash (Debt)	29.12	18.58	11.7	26.98	-0.03
Net Cash Growth	56.75%	58.77%	-56.64%	-	-
Net Cash Per Share	0.01	0.05	0.04	0.15	-
Filing Date Shares Outstanding	2,335	2,173	339.31	255.43	100
Total Common Shares Outstanding	2,335	460.37	339.31	255.43	100
Working Capital	24.92	5.27	3.07	19.39	-0.12
Book Value Per Share	0.02	0.06	0.13	0.25	-0.00
Tangible Book Value	-1.78	-20.96	-14.16	6.89	-0.12
Tangible Book Value Per Share	-0.00	-0.05	-0.04	0.03	-0.00

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.